Endometriosis lesions are oligoclonal structures derived from the normal endometrium

By utilizing somatic mutations as markers, this study demonstrates that endometriosis lesions are oligoclonal structures originating from the normal endometrium, characterized by unrelated epithelial clones and distinct stromal cells that share similar mutation burdens and driver landscapes with their uterine counterparts.

The Gist

The Big Mystery: Where Do Endometriosis Lesions Come From?

For nearly 100 years, doctors have debated a big question about endometriosis: a painful condition where tissue similar to the lining of the uterus grows in the wrong places (like the ovaries, bladder, or intestines).

There were two main theories:

1. The "Backflow" Theory (Sampson's Theory): Imagine the uterus as a house. Every month, the house gets cleaned out (menstruation). Sometimes, the trash (blood and tissue) doesn't just go out the front door; it gets blown backward through the pipes (fallopian tubes) into the backyard (the pelvis). If that trash lands on the grass, it might grow into a weed.
2. The "Transformation" Theory: Maybe the cells in the backyard (the peritoneum) suddenly decide to change their identity and turn into uterine tissue, like a caterpillar turning into a butterfly.
3. The "Stem Cell" Theory: Maybe stem cells from the bone marrow travel through the blood and build these lesions from scratch.

This new study acts like a high-tech detective, using DNA mutations as "fingerprints" to solve the case.

---

The Detective Work: DNA Fingerprints

Every cell in your body accumulates tiny, random typos in its DNA (mutations) as you age, kind of like how a photocopier gets slightly more grainy with every copy. These typos act as a lineage tracker.

• If two cells share the same specific typos, they are close relatives (siblings or cousins).
• If they have completely different typos, they are strangers who came from different ancestors.

The researchers took tiny samples of endometriosis tissue and normal uterine tissue from 25 women. They sequenced the DNA of individual glands to see who was related to whom.

The Three Big Discoveries

1. The "Poly-Clonal" Garden (Lesions are made of strangers)

The researchers expected to find that a single "bad seed" grew into a large lesion. Instead, they found that a single lesion is actually a crowd of unrelated strangers.

• The Analogy: Imagine a patch of weeds in your garden. You might expect one seed to blow in and grow a huge bush. But this study found that a single patch of weeds is actually made of 10 different seeds that blew in at different times from different places. They are growing side-by-side, but they aren't related.
• The Finding: Even a tiny 2mm piece of endometriosis contains multiple, unrelated clones of cells. This means the body isn't spreading one bad lesion; it's constantly getting "seeded" with new, independent bits of tissue.

2. The "Identity Card" (They are definitely uterine tissue)

Some theories suggested these lesions might be transformed skin cells or bone marrow cells. The researchers checked the "epigenetic landscape" (the way the DNA is packaged) to see what kind of cell the lesions used to be.

• The Analogy: Think of a person who moves to a new country and changes their accent. If you analyze their DNA history, you can still tell where they were born.
• The Finding: The DNA "accent" of the endometriosis cells matched perfectly with the normal lining of the uterus. They did not match skin, bone marrow, or other tissues. This confirms the "Backflow" theory: these cells are definitely from the uterus.

3. The "Missing Link" (Finding the parent in the house)

This is the most exciting part. The researchers took the entire uterus from three women who had hysterectomies. They sliced the uterus into hundreds of tiny pieces and searched for the exact DNA "fingerprints" found in the endometriosis lesions outside the body.

• The Analogy: Imagine you find a lost child in a park (the lesion). You take their DNA and search the entire neighborhood (the uterus) to find their parents.
• The Finding: In two of the three women, they found the exact parent clones living inside the normal uterus. They could even estimate when the "child" left the house (around age 17 or 18). This proves that the lesions started as normal uterine tissue that traveled out of the uterus.

What Does This Mean for Patients?

1. It's a Repeated Event: Since lesions are made of unrelated clones, it means the "seeding" happens repeatedly throughout a woman's life. It's not just one bad event; it's a continuous process.
2. Surgery Might Not Be the Only Answer: Because the lesions don't spread from one another like cancer (metastasis), removing one lesion doesn't necessarily stop new ones from forming. The "seeding" continues as long as the woman has periods.
3. Prevention Strategy: This supports treatments that stop or reduce menstruation (like hormonal birth control) to stop the "trash" from blowing backward into the pelvis.
4. Drug Hope: They found that some lesions have a specific mutation called KRAS. While this mutation is common in cancer, the study showed it's not the only thing driving the disease. However, it opens the door to testing cancer drugs that target KRAS for endometriosis, though they likely won't be a "cure-all" since the lesions are so complex.

The Bottom Line

This study confirms that endometriosis is caused by normal uterine tissue traveling backward into the pelvis (retrograde menstruation). These lesions are not single monsters growing from one cell; they are oligoclonal (made of many unrelated families) that arrive repeatedly over a woman's life. The "bad seeds" are actually just normal uterine cells that got lost on their way out.

Technical Summary

1. Problem Statement

Endometriosis is a chronic condition affecting ~10% of reproductive-age women, characterized by endometrial-like tissue growing outside the uterus. The etiology and mechanisms of dissemination remain debated. Leading theories include:

• Retrograde Menstruation: Cells reflux through fallopian tubes (Sampson's theory).
• Coelomic Metaplasia: Transformation of peritoneal mesothelial cells.
• Müllerian Remnants: Displaced fetal cells.
• Stem Cell Recruitment: Circulating stem cells (uterine or bone marrow origin).

A critical unresolved question is whether lesions spread via metastasis from a single founder lesion or are independently seeded by distinct progenitor cells. Furthermore, the cellular origin of the ectopic tissue (uterine vs. non-uterine) lacks definitive functional evidence.

2. Methodology

The study employed a high-resolution somatic mutation tracing approach to reconstruct the developmental history of endometriosis lesions.

• Cohort: 25 women undergoing laparoscopic surgery for endometriosis at Landspitali University Hospital (Iceland).
• Sample Collection:
  • Laser Capture Microdissection (LCM) was used to isolate individual endometrial glands (epithelium) and stromal cells from lesions (superficial, deep-infiltrating, endometriomas) and matched normal endometrium.
  • Total dataset: 403 microdissections (315 epithelial from lesions, 85 from normal endometrium, 3 adjacent stroma, 3 adenomyosis).
  • Special Case: Three patients underwent hysterectomy, allowing for the isolation of the entire uterine endometrium, which was segmented into ~286 small pieces (approx. 2x2mm) for a "capture-recapture" screen.
• Sequencing: Whole-Genome Sequencing (WGS) performed on microdissected samples (median depth 19X).
• Bioinformatics & Analysis:
  • Mutation Calling: Identified 213,280 substitutions and 11,071 indels.
  • Phylogenetics: Reconstructed phylogenetic trees using MPBoot to visualize clonal relationships within and between lesions.
  • Mutational Signatures: Extracted COSMIC signatures (SBS1, SBS5, SBS18) using a Bayesian hierarchical Dirichlet process.
  • Driver Analysis: Used dNdScv to identify genes under positive selection (e.g., KRAS, PIK3CA).
  • Cell-of-Origin Inference: Correlated the genomic distribution of somatic mutations with epigenetic landscapes (histone marks) of 65 different cell types to determine the tissue of origin.
  • Targeted Screening: In the hysterectomy cases, PCR-based targeted sequencing was used to search for specific "mutation barcodes" (sets of 10 mutations) identified in lesions within the segmented normal endometrium.

3. Key Contributions

• First High-Resolution Clonal Mapping: Provided the first comprehensive phylogenetic reconstruction of endometriosis lesions, revealing their oligoclonal nature.
• Definitive Cell-of-Origin Evidence: Used somatic mutation distribution patterns (epigenetic memory) to prove that ectopic lesions share a lineage with the normal endometrium, ruling out metaplasia or circulating stem cell origins.
• Capture-Recapture Validation: Successfully traced specific endometriosis clones back to their ancestral location within the normal uterine endometrium, providing direct functional proof of the retrograde menstruation hypothesis.
• Dissemination Mechanism: Demonstrated that lesions are independently seeded rather than spreading via metastasis from a single founder.

4. Key Results

A. Mutation Burden and Signatures

• Similarity to Normal Tissue: Lesional epithelial cells exhibit a mutation burden (~23.3 mutations/cell/year) and mutational signatures (dominated by SBS1, SBS5, SBS18) statistically indistinguishable from normal endometrium.
• Driver Landscape: No significant difference in driver mutation frequency between lesions and normal tissue after correcting for clonal structure. KRAS hotspot mutations were found in 16% of lesion microdissections vs. 4% of normal glands, but these often preceded clonal expansion and were not statistically distinct when accounting for clonal structure.

B. Clonal Architecture (Oligoclonality)

• Polyclonal Lesions: Individual lesions (even within a 2-3mm strip) typically comprise multiple unrelated clones of epithelial cells.
• Stromal Independence: Stromal cells adjacent to epithelial glands share no mutations with the epithelium, indicating they are a polyclonal mix recruited separately or traveling with the epithelium, rather than arising from a single bipotential ancestor.
• Independent Seeding: Lesions at different body sites (e.g., bladder vs. ovary) within the same patient consist of entirely distinct, unrelated clones. There is no evidence of a "founder lesion" seeding other sites (metastasis-like spread).

C. Cell-of-Origin Analysis

• Epigenetic Matching: The distribution of somatic mutations along chromosomes in lesions best matched the epigenetic landscape of the normal endometrium (P=6×10⁻⁷), outperforming ovarian surface epithelium, hematopoietic stem cells, or mesenchymal stem cells.
• Rejection of Alternatives: Early mutations in lesions (pre-divergence) still matched the endometrial signature, refuting the metaplasia theory (which would predict an early non-endometrial signature) and the circulating stem cell theory.

D. Capture-Recapture Screening

• In two of three patients with whole-uterus screening, specific clones identified in lesions (including a deep-infiltrating lesion on the sacrouterine ligament) were successfully located in the normal endometrium.
• Timing: Based on mutation accumulation rates, the seeding event for one traced clone was estimated to have occurred when the patient was approximately 17–19 years old (near menarche).

5. Significance and Implications

• Validation of Sampson's Theory: The study provides the first functional, molecular evidence supporting retrograde menstruation as the primary mechanism of endometriosis seeding.
• Clinical Management:
  • Prevention: Since seeding is a repeated event throughout life, strategies limiting the number of menstrual cycles (e.g., continuous hormonal suppression) are biologically justified to prevent new lesion formation.
  • Surgery: Existing lesions do not appear to seed new ones; therefore, delaying surgery may not accelerate disease spread, though it does not stop new seeding events.
  • Therapeutics: While KRAS mutations are present, they are not ancestral to the entire lesion (often arising post-seeding). This suggests that KRAS inhibitors would likely be non-curative for the disease as a whole, though they might target specific sub-clones.
• Paradigm Shift: Endometriosis is redefined not as a metastatic cancer-like process, but as a condition of repeated, independent seeding of normal endometrial clones into ectopic sites, resulting in oligoclonal, polyclonal structures.